The numbers of FSP1 + podocytes are elevated in mice treated with adriamycin (ADR), a model of human focal and segmental glomerulosclerosis (FSGS), and they positively correlate with the severity of proteinuria and glomerulosclerosis. This evidence concerns the gene S100A4 and focal segmental glomerulosclerosis.